Cantargia

IPO

Leaders in antibody technology targeting IL1RAP

Cantargia was founded in 2010, is headquartered in Lund, Sweden, and has 1 recorded funding round.

Headquarters
Lund
Founded
2010
Business Model
B2B
Rounds
1
Type
Public

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

Cantargia is a Swedish biotechnology company that specializes in the development of pharmaceuticals for various types of cancer and inflammatory/autoimmune diseases. Cantargia AB was founded in 2010 by the researchers Thoas Fioretos, Marcus Järås and Kjell Sjöström with the goal to refine a discovery made by Professor Fioretos and Doctor Järås at Lund University. Cantargia has brought two candidate drugs into clinical development, nadunolimab (CAN04) and CAN10, where the latter was acquired by Otsuka Pharmaceutical in 2025, and the company is listed on Nasdaq Stockholm's Main List under the ticker CANTA.

Summary

Cantargia is a Biotech company based in Lund, Sweden, founded in 2010.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOVenture RoundJan 2015

Sign up to see all 2 events

Funding, valuations, and company events, with amounts and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cantargia on Indexed.vc
<a href="https://indexed.vc/companies/cantargia"><img src="https://indexed.vc/api/badge/company/cantargia" alt="Cantargia on Indexed.vc" width="260" height="76" /></a>